NCT01123824 Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects Status COMPLETED Phase PHASE1
NCT01120457 First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers Status COMPLETED Phase PHASE1
NCT01112423 Safety Study of BMS-823778 in Subjects With Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT01111955 Safety Study of BMS-823778 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01108705 Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment Status TERMINATED Phase PHASE3
NCT01107886 Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications Status COMPLETED Phase PHASE4
NCT01105429 Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01097642 Neo-Adjuvant Study in Triple Negative Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT01096043 A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure Status COMPLETED Phase PHASE2
NCT01092728 Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma Status TERMINATED Phase PHASE2
NCT01092325 Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure Status COMPLETED Phase PHASE1/PHASE2
NCT01088360 Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01086319 Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments Status COMPLETED Phase N/A